Sage Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Pipeline Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. ACN
5. IBM
6. META
7. SPY
8. NVDA
9. PRIM
10. PFE

Go back to Sage Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Pipeline Update

SAGE Therapeutics (SAGE) Tops Q4 EPS by 24c

February 22, 2018 6:30 AM EST

SAGE Therapeutics (NASDAQ: SAGE) reported Q4 EPS of ($1.75), $0.24 better than the analyst estimate of ($1.99).

For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.

... More